Caricamento...
Updates on Immune Therapies in Type 1 Diabetes
Multiple clinical trials investigating the efficacy and safety of immunotherapeutic interventions in new onset type 1 diabetes (T1D) have failed to yield long term clinical benefit. Lack of efficacy has frequently been attributed to an incomplete understanding of the pathways involved in T1D and the...
Salvato in:
| Pubblicato in: | Eur Endocrinol |
|---|---|
| Autori principali: | , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Touch Medical Media
2016
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5813448/ https://ncbi.nlm.nih.gov/pubmed/29632594 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.17925/EE.2016.12.02.89 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|